Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Neuroscience · India · 2021-12-01

Processing Time
303 days
Decision Date
2021-12-01
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into the cellular and molecular mechanisms of memory function, specifically focusing on the use of spermidine as a pharmacological intervention to hinder age-related memory loss. Her work aims to identify metabolic pathways, such as energy metabolite acetyl-coA production, to optimize treatment plans for cognitive disorders.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses age-induced cognitive disorders, which are a growing concern for the aging global and U.S. population.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a strong track record of publications, high citations, and a patent application.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's unique expertise and the significant impact of her findings on public health justify the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in genetics, a record of 7 peer-reviewed scientific articles, and 785 citations from 48 countries. Additionally, she demonstrated her influence through 10 peer reviews for 3 journals, a U.S. patent application, and funding from 18 prestigious sources including the European Union and the German Research Foundation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Others

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
Georgia 79 days 2023-02-16
The petitioner proposes to continue research on elucidating the inhibitory mechanisms underlying new learning and memory formation. This work aims to develop novel therapeutic strategies and improve treatment outcomes for neurological conditions such as Alzheimer’s disease by gaining a fuller understanding of molecular processes.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
California 474 days 2025-03-07
The petitioner proposes to continue research into the cellular and molecular mechanisms of learning and memory to identify new therapeutic targets for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. The work involves identifying specific neuronal dynamics and molecular mechanisms to decrease mortality and reduce national healthcare expenditures associated with neurological disorders.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.
View Case

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Minnesota 41 days 2025-08-18
The petitioner proposes to develop effective protease inhibitors that achieve stronger enrichment in the brain to reduce tau-induced neurotoxicity. This work specifically targets the progression of Alzheimer’s disease and related dementias through the design of small-molecule inhibitors. The research aims to address the medical and social challenges posed by the growing prevalence of dementia in aging populations.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-12-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 303 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist